A Comparison of Hearing Aid Noise Programs on Speech Intelligibility

NCT ID: NCT06957730

Last Updated: 2025-05-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

17 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-04-22

Study Completion Date

2025-05-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Hearing impaired participants will be fit with study devices which will have three different hearing aid programs. Speech intelligibility will be measured using validated tests for each of the three hearing aid programs. The order of the hearing aid programs will be randomized across participants and each participant will be blinded as to the programs being tested.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Program 1 is the current default in the commercially available devices. Programs 2 and 3 are being tested against the current default.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hearing Loss, Bilateral or Unilateral

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

All participants will be tested with the same three hearing aid programs, but the order of the programs will be randomized for each participant.
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Phonak Audeo RIC

All participants are fit with the Audeo RIC hearing aids, which are programmed with three different settings. All participants are tested with all three settings.

Group Type EXPERIMENTAL

Phonak Audeo Infinio Hearing Aid

Intervention Type DEVICE

Commercially available receiver-in-canal (RIC) style hearing aid manufactured by Sonova.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Phonak Audeo Infinio Hearing Aid

Commercially available receiver-in-canal (RIC) style hearing aid manufactured by Sonova.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Bilateral moderate to severe hearing loss (N3-N4)
* Experienced hearing aid user
* Fluent in English
* Cognitively able to complete complex listening tasks

Exclusion Criteria

* Unilateral hearing loss
* New hearing aid user
* Unable or unwilling to complete complex listening tasks
Minimum Eligible Age

18 Years

Maximum Eligible Age

95 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sonova AG

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Phonak Audiology Research Center

Aurora, Illinois, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SRF-29404

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.